Results: Thirty-one CLI pairs were matched and analyzed (71.0% vs 64.5% in dialysis, 80.6% vs 83.9% in diabetes, and 54.8% vs 48.4% in ischemic heart disease, for UGNB vs GA, respectively). IPABG with UGNB included five below-knee popliteal bypasses, on the other hand, IPABGs with GA were totally distal bypasses (P ¼ .02). Intraoperatively, operation time was longer in UGNB (401 6 107 vs 341 6 107 minutes; P ¼ .04), whereas the amount of dopamine, infusion, and blood transfusion was less in UGNB (0.67 6 0.75 vs 1.53 6 1.99 mg/kg, P ¼ .03; 1700 6 800 vs 2812 6 1195 mL, P < .01; and 237 6 342 vs 462 6 321 mL, P ¼ .02, respectively) despite of equal blood loss (280 vs 296 mL; P ¼ .81). Postoperatively, starting timing of drinking and diet after surgery were 0.61 days and 0.97 days in UGNB and 1.45 days and 2.48 days in GA, respectively (P < .01 for each). The amount of postoperative blood transfusion was less in UGNB (1242 6 1036 vs 2264 6 1298 mL, P < .01; and 147 6 172 vs 352 6 409, P ¼ .01, respectively). Postoperative delirium occurred significantly less in UGNB (19.4% vs 48.4%; P ¼ .02). No early mortality was seen in UGNB compared with one patient in GA (3.2%; P ¼ .3). Early thrombosed graft was seen in two limbs (6.5%) in UGNB and in one limb in GA (3.2%), but was not significant.
FT15. Endovascular vs Open Treatment of Severe Aortoiliac Occlusive Disease: Outcomes of Kissing Self-Expanding Covered Stent for Reconstruction of the Aortic Bifurcation
Sandro Lepidi, MD, Francesco Squizzato, MD, Riccardo Bozza, MD, Laura Ventura, MD, Marco Zavatta, MD, Michele Piazza, MD, Franco Grego, MD, Michele Antonello, MD. University of Padova, Padova University, Padua, Italy Objectives: Self-expanding covered stents (SECS) have been used to reconstruct the aortic bifurcation and re-establish a normal iliac flow in patients with complex aortoiliac occlusive disease (AIOD), classified as TASC-II type C and D (Fig 1) . Aim of the study was to retrospectively compare SECS with aortobifemoral bypass (ABF) in TASC-II C and D AIOD lesions. Primary end points were perioperative and midterm results. Preoperative risk factors and clinical and anatomical presentations were analyzed.
Methods: A prospectively maintained database was searched for TASC-II C/D AIOD patients, treated with SECS or ABF. Indication to treatment was severe claudication or critical limb ischemia (Rutherford categories). Operative comorbidity risk was assessed using the Society for Vascular Surgery (SVS) comorbidity grading system. SECS technique consisted of bilateral femoral approach (percutaneous or open), retrograde or antegrade lesion crossing, predilatation using small-diameter balloons, kissing SECS deployment in the aortoiliac lesions, and final postdilatation to the appropriate diameter. SECS included Viabahn (W. L. Gore) and Fluency (Bard) grafts. Concomitant femoral artery endarterectomy was performed in both groups, when needed. Clinical and duplex scan evaluation was performed at 3, 6, and 12 months and then yearly. Statistical analyses were performed using the free R software.
Results: From January 2009 to November 2016, 100 consecutive patients were included in the study (50 SECS and 50 ABF). No difference was observed between the two groups regarding preoperative Rutherford category distribution (P ¼ .39). SECS group showed significantly less advanced TASC lesions (27 vs 42 TASC D; P ¼ .002) and significantly greater total SVS comorbidity score (1 6 0.53 vs 0.79 6 0.46; P ¼ .047). Cumulative perioperative surgical complications were 5% in SECS and 6% in ABF group, whereas medical complications were 2% in SECS and 10% in ABF, including one death (P ¼ .20). The mean follow-up was 27 6 21 months. Kaplan-Meyer analysis (Fig 2) showed a primary patency estimate of 94.9% (95% confidence interval, 89%-100%) and 89.2% (95% confidence interval, 81%-99%) in the SECS and ABF group, respectively (P ¼ .85). Based on a Cox proportional hazard regression analysis, among all preoperative variables, only Rutherford category (hazard ratio, 3.04; P ¼ .01) and SVS score (hazard ratio, 0.22; P ¼ .10) proved to be prognostic factors of primary patency. Similarly, a logistic regression model with dependent variable patency indicated as significant factors only Rutherford category (P ¼ .02) and SVS score (P ¼ .05).
Conclusions: Endovascular treatment using SECS showed no statistical difference in perioperative and follow-up results as compared to open repair. Rutherford category and SVS score were the only variables able to influence long-term follow-up results.
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